International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Lansoprazole 3-mg/mL in Ora-Blend Suspension

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2022 - Volume 26, Number 5
View All Articles in Issue

Page(s): 429

Lansoprazole 3-mg/mL in Ora-Blend Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Lansoprazole 3-mg/mL in Ora-Blend Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: lansoprazole, formulations, procedure to ensure stability of aqueous solutions of sodium bicarbonate if autoclaved, gastric acid secretion inhibitor, gastroesophageal reflux disease, GERD

Related Categories: FORMULATIONS, GASTROENTEROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Lansoprazole 3-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2022 Pg. 429
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A	Mar/Apr 2011 Pg. 124-128
Lansoprazole 3-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2010 Pg. 246
Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension	May/Jun 2018 Pg. 263
Lansoprazole 3-mg/mL Oral Liquid Allen Loyd V Jr	Jan/Feb 2007 Pg. 74
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Lansoprazole 3-mg/mL Oral Suspension	Jan/Feb 2025 Pg. 46
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Allen Loyd V Jr	Jan/Feb 2019 Pg. 58
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 148
Cilazapril 1-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 413
Clonidine 0.01-mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 414
Basics of Compounding for Raynaud's Disease Glasnapp Andrew	Jul/Aug 2003 Pg. 288-291
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren	Mar/Apr 2020 Pg. 140-147
Metronidazole 50 mg/mL in Ora-Blend Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 52
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S	Jul/Aug 2001 Pg. 314-319
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Quetiapine Fumarate 10 mg/mL in Ora-Blend Allen Loyd V Jr	Nov/Dec 2021 Pg. 506
Treating Canine Hepatic Disease Davidson Gigi S	May/Jun 2003 Pg. 188-191
Return to Top